Industries > Pharma > Global Defibrillators Market Forecast 2017-2026

Global Defibrillators Market Forecast 2017-2026

External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators

PUBLISHED: 07 December 2016
PAGES: 180
PRODUCT CODE: PHA0156
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0156 Categories: ,

The global defibrillators market is expected to grow at a CAGR of 5.3% from 2016-2020 and CAGR of 5.1% from 2020-2026. The market is expected to grow at a CAGR of 5.2% from 2016 to 2026. The market is estimated at $9.84bn in 2016, $12.07bn in 2020, and $16.29bn in 2026.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 180-page report you will receive 75 tables and 93 charts – all unavailable elsewhere.

The 180 page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Defibrillators Market Forecast 2017-2026

Report Scope

Global Defibrillators Market forecast 2017-2026

• Global Defibrillators National Market forecast 2017-2026, covering:

– North America:
• US
• Canada

– Europe:
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

– Asia-Pacific:
• Japan
• China
• India
• Rest of Asia-Pacific

– Rest of the World:
• Latin America
• Middle East
• Africa

• Global Defibrillators submarket forecasts, by product, 2017-2026:

– Implantable Cardioverter Defibrillators (ICDs)
• Transvenous ICDs (T-ICDs):

– Single-Chamber ICDs
– Dual-Chamber ICDs
– Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

• Subcutaneous ICDs (S-ICDs)

– External Defibrillators
• Manual External Defibrillators
• Automated External Defibrillators (AEDs):

– Semi-Automated External Defibrillators
– Fully-Automated External Defibrillators

• Wearable Cardioverter Defibrillators (WCDs)

• Global Defibrillators submarket forecasts, by end user, 2017-2026
– Hospitals and Cardiac Centers
– Pre-hospital Services
– Public Access
– Home Care
– Other-End User

• Analysis of the key factors driving and restraining the growth of the defibrillators market from 2017-2026

• Assessment of selected leading companies, examining recent performance and outlooks:
– Medtronic PLC
– Boston Scientific Corporation
– Biotronik SE & Co. KG
– St Jude Medical
– LivaNova PLC
– Zoll Medical Corporation
– Physio Control Inc.
– Cardiac Science Corporation
– Nihon Kohden Corporation
– Phillips Healthcare

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.

Buy our report today Global Defibrillators Market Forecast 2017-2026: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2017-2026


Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2017-2026


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories